Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |